Global Blockchain in Pharma Supply Chain 麻豆原创 Research Report 2023

Publication ID:

PB502242455

Publication Date:

February 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Given that blockchain technology allows the secure creation听and sharing of time-stamped records among numerous parties in real time, it isn鈥檛 surprising that it might be of interest for improving the pharmaceutical supply chain. Pharmaceutical companies aren鈥檛 stopping there, though. Blockchain technology is being explored for drug discovery, clinical trials and much more.
Highlights
The global Blockchain in Pharma Supply Chain market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Blockchain in Pharma Supply Chain is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Blockchain in Pharma Supply Chain is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Blockchain in Pharma Supply Chain in Supply Chain Management is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Blockchain in Pharma Supply Chain include IBM, AWS, Microsoft, SAP, Chronicled, Doc.AI, Embleema, Factom Inc. and FarmaTrust, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blockchain in Pharma Supply Chain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blockchain in Pharma Supply Chain.
The Blockchain in Pharma Supply Chain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blockchain in Pharma Supply Chain market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blockchain in Pharma Supply Chain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
IBM
AWS
Microsoft
SAP
Chronicled
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
Medicalchain
Huawei
Segment by Type
Public Blockchain
Private Blockchain
Segment by Application
Supply Chain Management
Drug Development
Clinical Trials
Internet of Medical Things (IOMT) & Cyber Security
Other Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blockchain in Pharma Supply Chain companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Blockchain in Pharma Supply Chain 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Public Blockchain
1.2.3 Private Blockchain
1.3 麻豆原创 by Application
1.3.1 Global Blockchain in Pharma Supply Chain 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Supply Chain Management
1.3.3 Drug Development
1.3.4 Clinical Trials
1.3.5 Internet of Medical Things (IOMT) & Cyber Security
1.3.6 Other Applications
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blockchain in Pharma Supply Chain 麻豆原创 Perspective (2018-2029)
2.2 Blockchain in Pharma Supply Chain Growth Trends by Region
2.2.1 Global Blockchain in Pharma Supply Chain 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Blockchain in Pharma Supply Chain Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Blockchain in Pharma Supply Chain Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Blockchain in Pharma Supply Chain 麻豆原创 Dynamics
2.3.1 Blockchain in Pharma Supply Chain Industry Trends
2.3.2 Blockchain in Pharma Supply Chain 麻豆原创 Drivers
2.3.3 Blockchain in Pharma Supply Chain 麻豆原创 Challenges
2.3.4 Blockchain in Pharma Supply Chain 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blockchain in Pharma Supply Chain Players by Revenue
3.1.1 Global Top Blockchain in Pharma Supply Chain Players by Revenue (2018-2023)
3.1.2 Global Blockchain in Pharma Supply Chain Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Blockchain in Pharma Supply Chain 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blockchain in Pharma Supply Chain Revenue
3.4 Global Blockchain in Pharma Supply Chain 麻豆原创 Concentration Ratio
3.4.1 Global Blockchain in Pharma Supply Chain 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blockchain in Pharma Supply Chain Revenue in 2022
3.5 Blockchain in Pharma Supply Chain Key Players Head office and Area Served
3.6 Key Players Blockchain in Pharma Supply Chain Product Solution and Service
3.7 Date of Enter into Blockchain in Pharma Supply Chain 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Blockchain in Pharma Supply Chain Breakdown Data by Type
4.1 Global Blockchain in Pharma Supply Chain Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Blockchain in Pharma Supply Chain Forecasted 麻豆原创 Size by Type (2024-2029)
5 Blockchain in Pharma Supply Chain Breakdown Data by Application
5.1 Global Blockchain in Pharma Supply Chain Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Blockchain in Pharma Supply Chain Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Blockchain in Pharma Supply Chain 麻豆原创 Size (2018-2029)
6.2 North America Blockchain in Pharma Supply Chain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2018-2023)
6.4 North America Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blockchain in Pharma Supply Chain 麻豆原创 Size (2018-2029)
7.2 Europe Blockchain in Pharma Supply Chain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2018-2023)
7.4 Europe Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blockchain in Pharma Supply Chain 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Blockchain in Pharma Supply Chain 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Blockchain in Pharma Supply Chain 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Blockchain in Pharma Supply Chain 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blockchain in Pharma Supply Chain 麻豆原创 Size (2018-2029)
9.2 Latin America Blockchain in Pharma Supply Chain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blockchain in Pharma Supply Chain 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Blockchain in Pharma Supply Chain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Blockchain in Pharma Supply Chain 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Blockchain in Pharma Supply Chain Introduction
11.1.4 IBM Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.1.5 IBM Recent Development
11.2 AWS
11.2.1 AWS Company Detail
11.2.2 AWS Business Overview
11.2.3 AWS Blockchain in Pharma Supply Chain Introduction
11.2.4 AWS Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.2.5 AWS Recent Development
11.3 Microsoft
11.3.1 Microsoft Company Detail
11.3.2 Microsoft Business Overview
11.3.3 Microsoft Blockchain in Pharma Supply Chain Introduction
11.3.4 Microsoft Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.3.5 Microsoft Recent Development
11.4 SAP
11.4.1 SAP Company Detail
11.4.2 SAP Business Overview
11.4.3 SAP Blockchain in Pharma Supply Chain Introduction
11.4.4 SAP Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.4.5 SAP Recent Development
11.5 Chronicled
11.5.1 Chronicled Company Detail
11.5.2 Chronicled Business Overview
11.5.3 Chronicled Blockchain in Pharma Supply Chain Introduction
11.5.4 Chronicled Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.5.5 Chronicled Recent Development
11.6 Doc.AI
11.6.1 Doc.AI Company Detail
11.6.2 Doc.AI Business Overview
11.6.3 Doc.AI Blockchain in Pharma Supply Chain Introduction
11.6.4 Doc.AI Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.6.5 Doc.AI Recent Development
11.7 Embleema
11.7.1 Embleema Company Detail
11.7.2 Embleema Business Overview
11.7.3 Embleema Blockchain in Pharma Supply Chain Introduction
11.7.4 Embleema Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.7.5 Embleema Recent Development
11.8 Factom Inc.
11.8.1 Factom Inc. Company Detail
11.8.2 Factom Inc. Business Overview
11.8.3 Factom Inc. Blockchain in Pharma Supply Chain Introduction
11.8.4 Factom Inc. Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.8.5 Factom Inc. Recent Development
11.9 FarmaTrust
11.9.1 FarmaTrust Company Detail
11.9.2 FarmaTrust Business Overview
11.9.3 FarmaTrust Blockchain in Pharma Supply Chain Introduction
11.9.4 FarmaTrust Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.9.5 FarmaTrust Recent Development
11.10 Guardtime Federal
11.10.1 Guardtime Federal Company Detail
11.10.2 Guardtime Federal Business Overview
11.10.3 Guardtime Federal Blockchain in Pharma Supply Chain Introduction
11.10.4 Guardtime Federal Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.10.5 Guardtime Federal Recent Development
11.11 Hashed Health
11.11.1 Hashed Health Company Detail
11.11.2 Hashed Health Business Overview
11.11.3 Hashed Health Blockchain in Pharma Supply Chain Introduction
11.11.4 Hashed Health Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.11.5 Hashed Health Recent Development
11.12 Medicalchain
11.12.1 Medicalchain Company Detail
11.12.2 Medicalchain Business Overview
11.12.3 Medicalchain Blockchain in Pharma Supply Chain Introduction
11.12.4 Medicalchain Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.12.5 Medicalchain Recent Development
11.13 Huawei
11.13.1 Huawei Company Detail
11.13.2 Huawei Business Overview
11.13.3 Huawei Blockchain in Pharma Supply Chain Introduction
11.13.4 Huawei Revenue in Blockchain in Pharma Supply Chain Business (2018-2023)
11.13.5 Huawei Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

IBM
AWS
Microsoft
SAP
Chronicled
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
Medicalchain
Huawei

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.